Travere Therapeutics (NASDAQ:TVTX) is in focus after a fresh update tied to rare disease therapies, with market attention on ...

Otsuka Pharmaceutical's Voyxact (sibeprenlimab-szsi) stabilised kidney function for over two years in patients with primary IgA nephropathy (IgAN) at risk for disease progression.

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The Company ...

September Nasdaq 100 E-Mini futures (NQU26) are up +0.67% this morning, signaling further gains for tech stocks as ...

The Traverse City shelter saved more than 90% of the dogs and cats that entered its care, meeting the benchmark requiring a ...

Detailed price information for Rani Therapeutics Holdings Inc Cl A (RANI-Q) from The Globe and Mail including charting and trades.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

TransMedics Group, Inc. ("TransMedics") , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Summit Therapeutics (SMMT) and Argenx Se (ARGX) with bullish sentiments. According to TipRanks.com, Azar ...

Use the IBD Stock Checklist to separate the wheat from the chaff in the stock market, specifically in the red-hot biotech ...

The Second Circuit closed the books on a novel issue that arose after Evan Greebel was convicted of securities fraud—whether ...